{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:49:08Z","timestamp":1790797748355,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Research and the Science and Technology Department of Sichuan Province","award":["2023YFS0220"],"award-info":[{"award-number":["2023YFS0220"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2304802"],"award-info":[{"award-number":["2022YFC2304802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11491-4","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T12:09:55Z","timestamp":1756728595000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment outcomes and associated influencing factors among elderly patients with rifampicin-resistant tuberculosis: a multicenter, retrospective, cohort study in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Huicong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaJia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingdong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouli","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"11491_CR1","unstructured":"World Health Organization. Global Tuberculosis Report 2024. 2024. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024"},{"key":"11491_CR2","first-page":"4","volume":"03","author":"SS Bureau","year":"2024","unstructured":"Bureau SS. Statistical bulletin of the National economic and social development of the people\u2019s Republic of China in 2023. Chin Stat. 2024;03:4\u201321.","journal-title":"Chin Stat"},{"issue":"9729","key":"11491_CR3","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/S0140-6736(10)60580-6","volume":"375","author":"PR Donald","year":"2010","unstructured":"Donald PR, Marais BJ, Barry CE. 3rd. Age and the epidemiology and pathogenesis of tuberculosis. Lancet (London England). 2010;375(9729):1852\u20134.","journal-title":"Lancet (London England)"},{"issue":"5","key":"11491_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1532-5415.2011.03369.x","volume":"59","author":"RH Pratt","year":"2011","unstructured":"Pratt RH, Winston CA, Kammerer JS, Armstrong LR. Tuberculosis in older adults in the united states, 1993\u20132008. J Am Geriatr Soc. 2011;59(5):851\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"11491_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cger.2016.02.006","volume":"32","author":"S Rajagopalan","year":"2016","unstructured":"Rajagopalan S. Tuberculosis in older adults. Clin Geriatr Med. 2016;32(3):479\u201391.","journal-title":"Clin Geriatr Med"},{"issue":"9934","key":"11491_CR6","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/S0140-6736(13)62639-2","volume":"383","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in china, 1990\u20132010; a longitudinal analysis of National survey data. Lancet (London England). 2014;383(9934):2057\u201364.","journal-title":"Lancet (London England)"},{"issue":"3","key":"11491_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.idc.2010.04.011","volume":"24","author":"T Mori","year":"2010","unstructured":"Mori T, Leung CC. Tuberculosis in the global aging population. Infect Dis Clin N Am. 2010;24(3):751\u201368.","journal-title":"Infect Dis Clin N Am"},{"key":"11491_CR8","first-page":"135","volume":"32","author":"J Negin","year":"2015","unstructured":"Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults\u2013time to take notice. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2015;32:135\u20137.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"issue":"1","key":"11491_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12879-024-09079-5","volume":"24","author":"H Lv","year":"2024","unstructured":"Lv H, Zhang X, Zhang X, et al. Global prevalence and burden of multidrug-resistant tuberculosis from 1990 to 2019. BMC Infect Dis. 2024;24(1):243.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"11491_CR10","doi-asserted-by":"publisher","first-page":"e0249565","DOI":"10.1371\/journal.pone.0249565","volume":"16","author":"NM Chaves-Torres","year":"2021","unstructured":"Chaves-Torres NM, Fadul S, Pati\u00f1o J, Netto E. Factors associated with unfavorable treatment outcomes in patients with rifampicin-resistant tuberculosis in Colombia 2013\u20132015: A retrospective cohort study. PLoS ONE. 2021;16(4):e0249565.","journal-title":"PLoS ONE"},{"issue":"3","key":"11491_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5588\/ijtld.18.0311","volume":"23","author":"M Makhmudova","year":"2019","unstructured":"Makhmudova M, Maxsumova Z, Rajabzoda A, Makhmadov A, van den Hof S, Mirtskhulava V. Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan. Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease. 2019;23(3):331\u20136.","journal-title":"Int J Tuberculosis Lung Disease: Official J Int Union against Tuberculosis Lung Disease"},{"key":"11491_CR12","first-page":"420","volume":"98","author":"A Alemu","year":"2020","unstructured":"Alemu A, Bitew ZW, Worku T. Poor treatment outcome and its predictors among drug-resistant tuberculosis patients in ethiopia: A systematic review and meta-analysis. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2020;98:420\u201339.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"issue":"04","key":"11491_CR13","first-page":"408","volume":"47","author":"H Li","year":"2025","unstructured":"Li H, Mei J, Su W. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021. Chin J Tuberculosis. 2025;47(04):408\u201315.","journal-title":"Chin J Tuberculosis"},{"issue":"09","key":"11491_CR14","first-page":"1023","volume":"46","author":"Z Ye","year":"2024","unstructured":"Ye Z, Ren F, Wang H. Treatment outcomes and influencing factors in elderly patients with multidrug\/rifampicin-resistant pulmonary tuberculosis: a National multicenter, retrospective cohort study. Chin J Tuberculosis. 2024;46(09):1023\u20139.","journal-title":"Chin J Tuberculosis"},{"issue":"6","key":"11491_CR15","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1590\/S1806-37132007000600013","volume":"33","author":"JP Cantalice Filho","year":"2007","unstructured":"Cantalice Filho JP, B\u00f3ia MN, Sant Anna CC. [Analysis of the treatment of pulmonary tuberculosis in elderly patients at a university hospital in Rio de janeiro, brazil]. Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia. 2007;33(6):691\u20138.","journal-title":"Jornal Brasileiro De Pneumologia: Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia"},{"issue":"2","key":"11491_CR16","doi-asserted-by":"publisher","first-page":"e88290","DOI":"10.1371\/journal.pone.0088290","volume":"9","author":"S Bele","year":"2014","unstructured":"Bele S, Jiang W, Lu H, et al. Population aging and migrant workers: bottlenecks in tuberculosis control in rural China. PLoS ONE. 2014;9(2):e88290.","journal-title":"PLoS ONE"},{"key":"11491_CR17","unstructured":"Organization WH. World Health Organization. Global Tuberculosis Report. 2018. https:\/\/www.who.int\/publications\/i\/item\/9789241565646"},{"issue":"26","key":"11491_CR18","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443\u201354.","journal-title":"N Engl J Med"},{"issue":"4","key":"11491_CR19","doi-asserted-by":"publisher","first-page":"e0175925","DOI":"10.1371\/journal.pone.0175925","volume":"12","author":"MH Workneh","year":"2017","unstructured":"Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: A systematic review. PLoS ONE. 2017;12(4):e0175925.","journal-title":"PLoS ONE"},{"issue":"1","key":"11491_CR20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/s41598-017-01213-5","volume":"7","author":"Q Liu","year":"2017","unstructured":"Liu Q, Li W, Xue M, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Sci Rep. 2017;7(1):1090.","journal-title":"Sci Rep"},{"key":"11491_CR21","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.2147\/IDR.S467971","volume":"17","author":"L Zou","year":"2024","unstructured":"Zou L, Kang W, Guo C, et al. Treatment outcomes and associated influencing factors among patients with Rifampicin-Resistant tuberculosis: A multicenter, retrospective, cohort study in China. Infect Drug Resist. 2024;17:3737\u201349.","journal-title":"Infect Drug Resist"},{"key":"11491_CR22","doi-asserted-by":"publisher","first-page":"1134938","DOI":"10.3389\/fpubh.2023.1134938","volume":"11","author":"J Lecai","year":"2023","unstructured":"Lecai J, Mijiti P, Chuangyue H, Qian G, Weiguo T, Jihong C. Treatment outcomes of multidrug-resistant tuberculosis patients receiving ambulatory treatment in shenzhen, china: a retrospective cohort study. Front Public Health. 2023;11:1134938.","journal-title":"Front Public Health"},{"key":"11491_CR23","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.2147\/IDR.S376177","volume":"15","author":"JB Ma","year":"2022","unstructured":"Ma JB, Zeng LC, Ren F, et al. Treatment outcomes and risk factors of Multidrug-Resistant tuberculosis patients in xi\u2019an china, a retrospective cohort study. Infect Drug Resist. 2022;15:4947\u201357.","journal-title":"Infect Drug Resist"},{"issue":"10","key":"11491_CR24","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1901814","volume":"382","author":"F Conradie","year":"2020","unstructured":"Conradie F, Diacon AH, Ngubane N, et al. Treatment of highly Drug-Resistant pulmonary tuberculosis. N Engl J Med. 2020;382(10):893\u2013902.","journal-title":"N Engl J Med"},{"issue":"5","key":"11491_CR25","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1056\/NEJMoa2400327","volume":"392","author":"L Guglielmetti","year":"2025","unstructured":"Guglielmetti L, Khan U, Vel\u00e1squez GE, et al. Oral regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible tuberculosis. N Engl J Med. 2025;392(5):468\u201382.","journal-title":"N Engl J Med"},{"issue":"8","key":"11491_CR26","doi-asserted-by":"publisher","first-page":"e040862","DOI":"10.1136\/bmjopen-2020-040862","volume":"11","author":"H Tola","year":"2021","unstructured":"Tola H, Holakouie-Naieni K, Mansournia MA, et al. National treatment outcome and predictors of death and treatment failure in multidrug-resistant tuberculosis in ethiopia: a 10-year retrospective cohort study. BMJ Open. 2021;11(8):e040862.","journal-title":"BMJ Open"},{"key":"11491_CR27","doi-asserted-by":"publisher","first-page":"229","DOI":"10.11604\/pamj.2021.38.229.28317","volume":"38","author":"A Kuaban","year":"2021","unstructured":"Kuaban A, Balkissou AD, Ekongolo MCE, Nsounfon AW, Pefura-Yone EW, Kuaban C. Incidence and factors associated with unfavourable treatment outcome among patients with rifampicin-resistant pulmonary tuberculosis in yaound\u00e9, Cameroon. Pan Afr Med J. 2021;38:229.","journal-title":"Pan Afr Med J"},{"key":"11491_CR28","doi-asserted-by":"publisher","unstructured":"Caraux-Paz P, Diamantis S, de Wazi\u00e8res B, Gallien S. Tuberculosis in the elderly. J Clin Med. 2021;10(24). https:\/\/doi.org\/10.3390\/jcm10245888","DOI":"10.3390\/jcm10245888"},{"issue":"6","key":"11491_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1136\/jech-2012-201640","volume":"67","author":"Z Udwadia","year":"2013","unstructured":"Udwadia Z, Vendoti D. Totally drug-resistant tuberculosis (TDR-TB) in india: every dark cloud has a silver lining. J Epidemiol Commun Health. 2013;67(6):471\u20132.","journal-title":"J Epidemiol Commun Health"},{"issue":"6","key":"11491_CR30","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/tmi.13066","volume":"23","author":"J Yin","year":"2018","unstructured":"Yin J, Wang X, Zhou L, Wei X. The relationship between social support, treatment interruption and treatment outcome in patients with multidrug-resistant tuberculosis in china: a mixed-methods study. Trop Med Int Health: TM IH. 2018;23(6):668\u201377.","journal-title":"Trop Med Int Health: TM IH"},{"key":"11491_CR31","first-page":"93","volume":"127","author":"F Wagnew","year":"2023","unstructured":"Wagnew F, Alene KA, Kelly M, Gray D. The effect of undernutrition on sputum culture conversion and treatment outcomes among people with multidrug-resistant tuberculosis: a systematic review and meta-analysis. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2023;127:93\u2013105.","journal-title":"Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis"},{"key":"11491_CR32","doi-asserted-by":"crossref","unstructured":"Chakhaia T, Blumberg HM, Kempker RR et al. Lack of weight gain and increased mortality during and after treatment among adults with drug-resistant tuberculosis in Georgia, 2009\u20132020. medRxiv: the preprint server for health sciences. 2024.","DOI":"10.1101\/2024.08.05.24311499"},{"key":"11491_CR33","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.puhe.2020.06.054","volume":"186","author":"A Badawi","year":"2020","unstructured":"Badawi A, Gregg B, Vasileva D. Systematic analysis for the relationship between obesity and tuberculosis. Public Health. 2020;186:246\u201356.","journal-title":"Public Health"},{"key":"11491_CR34","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.2147\/IDR.S457146","volume":"17","author":"S Hu","year":"2024","unstructured":"Hu S, Guo J, Chen Z, Gong F, Yu Q. Nutritional indices predict all cause mortality in patients with Multi-\/Rifampicin-Drug resistant tuberculosis. Infect Drug Resist. 2024;17:3253\u201363.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"11491_CR35","doi-asserted-by":"publisher","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","volume":"4","author":"JC Johnston","year":"2009","unstructured":"Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2009;4(9):e6914.","journal-title":"PLoS ONE"},{"issue":"5","key":"11491_CR36","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1183\/09031936.06.00125705","volume":"28","author":"CY Chiang","year":"2006","unstructured":"Chiang CY, Enarson DA, Yu MC, et al. Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study. Eur Respir J. 2006;28(5):980\u20135.","journal-title":"Eur Respir J"},{"issue":"9647","key":"11491_CR37","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0140-6736(08)61204-0","volume":"372","author":"S Keshavjee","year":"2008","unstructured":"Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in tomsk, russia: a retrospective cohort study. Lancet (London England). 2008;372(9647):1403\u20139.","journal-title":"Lancet (London England)"},{"issue":"6","key":"11491_CR38","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMc0706556","volume":"359","author":"ED Chan","year":"2008","unstructured":"Chan ED, Strand MJ, Iseman MD. Treatment outcomes in extensively resistant tuberculosis. N Engl J Med. 2008;359(6):657\u20139.","journal-title":"N Engl J Med"},{"key":"11491_CR39","doi-asserted-by":"crossref","unstructured":"Stephanie F, Saragih M, Tambunan USF. Recent progress and challenges for Drug-Resistant tuberculosis treatment. Pharmaceutics. 2021;13(5).","DOI":"10.3390\/pharmaceutics13050592"},{"issue":"2","key":"11491_CR40","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41577-022-00734-z","volume":"23","author":"RS Wallis","year":"2023","unstructured":"Wallis RS, O\u2019Garra A, Sher A, Wack A. Host-directed immunotherapy of viral and bacterial infections: past, present and future. Nat Rev Immunol. 2023;23(2):121\u201333.","journal-title":"Nat Rev Immunol"},{"key":"11491_CR41","doi-asserted-by":"publisher","first-page":"763591","DOI":"10.3389\/fcimb.2021.763591","volume":"11","author":"J Mi","year":"2021","unstructured":"Mi J, Liang Y, Liang J, et al. The research progress in immunotherapy of tuberculosis. Front Cell Infect Microbiol. 2021;11:763591.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"11491_CR42","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijtb.2019.04.002","volume":"66","author":"S Barzegari","year":"2019","unstructured":"Barzegari S, Afshari M, Movahednia M, Moosazadeh M. Prevalence of anemia among patients with tuberculosis: A systematic review and meta-analysis. Indian J Tuberc. 2019;66(2):299\u2013307.","journal-title":"Indian J Tuberc"},{"issue":"1","key":"11491_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pulmoe.2020.02.002","volume":"27","author":"R Singla","year":"2021","unstructured":"Singla R, Raghu B, Gupta A, et al. Risk factors for early mortality in patients with pulmonary tuberculosis admitted to the emergency room. Pulmonology. 2021;27(1):35\u201342.","journal-title":"Pulmonology"},{"key":"11491_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/nu14163318","volume":"14","author":"S Ashenafi","year":"2022","unstructured":"Ashenafi S, Bekele A, Aseffa G, et al. Anemia is a strong predictor of wasting, disease severity, and progression, in clinical tuberculosis (TB). Nutrients. 2022;14:16.","journal-title":"Nutrients"},{"issue":"2","key":"11491_CR45","doi-asserted-by":"publisher","first-page":"e0245458","DOI":"10.1371\/journal.pone.0245458","volume":"16","author":"EB de Mendon\u00e7a","year":"2021","unstructured":"de Mendon\u00e7a EB, Schmaltz CA, Sant\u2019Anna FM, et al. Anemia in tuberculosis cases: A biomarker of severity? PLoS ONE. 2021;16(2):e0245458.","journal-title":"PLoS ONE"},{"issue":"3","key":"11491_CR46","doi-asserted-by":"publisher","first-page":"e91229","DOI":"10.1371\/journal.pone.0091229","volume":"9","author":"TJ Nagu","year":"2014","unstructured":"Nagu TJ, Spiegelman D, Hertzmark E, et al. Anemia at the initiation of tuberculosis therapy is associated with delayed sputum conversion among pulmonary tuberculosis patients in Dar-es-Salaam, Tanzania. PLoS ONE. 2014;9(3):e91229.","journal-title":"PLoS ONE"},{"issue":"2","key":"11491_CR47","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3945\/jn.111.144287","volume":"142","author":"S Isanaka","year":"2012","unstructured":"Isanaka S, Mugusi F, Urassa W, et al. Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr. 2012;142(2):350\u20137.","journal-title":"J Nutr"},{"issue":"272","key":"11491_CR48","first-page":"1151","volume":"73","author":"CD Morris","year":"1989","unstructured":"Morris CD, Bird AR, Nell H. The haematological and biochemical changes in severe pulmonary tuberculosis. Q J Med. 1989;73(272):1151\u20139.","journal-title":"Q J Med"},{"issue":"5","key":"11491_CR49","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4110\/in.2011.11.5.245","volume":"11","author":"DM Shin","year":"2011","unstructured":"Shin DM, Jo EK. Antimicrobial peptides in innate immunity against mycobacteria. Immune Netw. 2011;11(5):245\u201352.","journal-title":"Immune Netw"},{"issue":"4","key":"11491_CR50","doi-asserted-by":"publisher","first-page":"e0195985","DOI":"10.1371\/journal.pone.0195985","volume":"13","author":"J Hella","year":"2018","unstructured":"Hella J, Cercamondi CI, Mhimbira F, et al. Anemia in tuberculosis cases and household controls from tanzania: contribution of disease, coinfections, and the role of Hepcidin. PLoS ONE. 2018;13(4):e0195985.","journal-title":"PLoS ONE"},{"issue":"1","key":"11491_CR51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/infdis\/jiv364","volume":"213","author":"AD Kerkhoff","year":"2016","unstructured":"Kerkhoff AD, Meintjes G, Burton R, Vogt M, Wood R, Lawn SD. Relationship between blood concentrations of Hepcidin and anemia severity, mycobacterial burden, and mortality among patients with HIV-Associated tuberculosis. J Infect Dis. 2016;213(1):61\u201370.","journal-title":"J Infect Dis"},{"issue":"1","key":"11491_CR52","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41598-018-37860-5","volume":"9","author":"L Gil-Santana","year":"2019","unstructured":"Gil-Santana L, Cruz LAB, Arriaga MB, et al. Tuberculosis-associated anemia is linked to a distinct inflammatory profile that persists after initiation of antitubercular therapy. Sci Rep. 2019;9(1):1381.","journal-title":"Sci Rep"},{"issue":"1","key":"11491_CR53","doi-asserted-by":"publisher","first-page":"2344821","DOI":"10.1080\/07853890.2024.2344821","volume":"56","author":"P Gu","year":"2024","unstructured":"Gu P, Lu P, Ding H, et al. Effectiveness, cost, and safety of four regimens recommended by WHO for RR\/MDR-TB treatment: a cohort study in Eastern China. Ann Med. 2024;56(1):2344821.","journal-title":"Ann Med"},{"issue":"4","key":"11491_CR54","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S2213-2600(20)30047-3","volume":"8","author":"Z Lan","year":"2020","unstructured":"Lan Z, Ahmad N, Baghaei P, et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respiratory Med. 2020;8(4):383\u201394.","journal-title":"Lancet Respiratory Med"},{"key":"11491_CR55","doi-asserted-by":"publisher","first-page":"1338902","DOI":"10.3389\/fphar.2024.1338902","volume":"15","author":"F Zou","year":"2024","unstructured":"Zou F, Cui Z, Lou S, et al. Adverse drug events associated with linezolid administration: a real-world pharmacovigilance study from 2004 to 2023 using the FAERS database. Front Pharmacol. 2024;15:1338902.","journal-title":"Front Pharmacol"},{"key":"11491_CR56","doi-asserted-by":"crossref","unstructured":"Guglielmetti L, Jaspard M, Le D\u00fb D et al. Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis. Eur Respir J. 2017;49(3).","DOI":"10.1183\/13993003.01799-2016"},{"issue":"11","key":"11491_CR57","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/cid\/ciab335","volume":"73","author":"JCM Brust","year":"2021","unstructured":"Brust JCM, Gandhi NR, Wasserman S, et al. Effectiveness and cardiac safety of Bedaquiline-Based therapy for Drug-Resistant tuberculosis: A prospective cohort study. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2021;73(11):2083\u201392.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"4","key":"11491_CR58","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.ijantimicag.2023.106939","volume":"62","author":"Y Jin","year":"2023","unstructured":"Jin Y, Benkeser D, Kipiani M, et al. The effect of anti-tuberculosis drug pharmacokinetics on QTc prolongation. Int J Antimicrob Agents. 2023;62(4):106939.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"11491_CR59","doi-asserted-by":"publisher","first-page":"107302","DOI":"10.1016\/j.ijantimicag.2024.107302","volume":"64","author":"J Kuhlin","year":"2024","unstructured":"Kuhlin J, Davies Forsman L, Osman A, et al. Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis. Int J Antimicrob Agents. 2024;64(4):107302.","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"11491_CR60","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/jac\/dkh199","volume":"53","author":"F Frippiat","year":"2004","unstructured":"Frippiat F, Bergiers C, Michel C, Dujardin JP, Derue G. Severe bilateral optic neuritis associated with prolonged linezolid therapy. J Antimicrob Chemother. 2004;53(6):1114\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"11491_CR61","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S1473-3099(24)00228-7","volume":"24","author":"O Korotych","year":"2024","unstructured":"Korotych O, Achar J, Gurbanova E, et al. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study. Lancet Infect Dis. 2024;24(10):1151\u201361.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"11491_CR62","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1183\/09031936.00022912","volume":"40","author":"G Sotgiu","year":"2012","unstructured":"Sotgiu G, Centis R, D\u2019Ambrosio L, et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J. 2012;40(6):1430\u201342.","journal-title":"Eur Respir J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11491-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11491-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:18:24Z","timestamp":1756901904000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11491-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11491"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11491-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the tenets of the Declaration of Helsinki and was approved by the Ethics Committee of Public Health Clinical Center of Chengdu as leading center (No.YJ-K2022-81-01). The present study was a retrospective study, the informed consent was waived signed, and all patient data were analyzed anonymously. The need for informed consent was waived by the Ethics Committee of Public Health Clinical Center of Chengdu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1086"}}